Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.6K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.6K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

776
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
776
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

29.2K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
29.2K
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

941
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
941
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

359
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
359

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying high-risk patient clusters for falls using unsupervised machine learning on linked primary and secondary care electronic health record data.

Scientific reports·2026
Same author

Understanding and Addressing Challenges With Electronic Health Record Use in Gynecological Oncology: Cross-Sectional Survey of Multidisciplinary Professionals in the United Kingdom and Co-Design of an Integrated Informatics Platform to Support Clinical Decision-Making.

JMIR cancer·2025
Same author

Long-term outcome of transurethral laser ablation for recurrent non-muscle invasive bladder cancer: An EORTC risk-matched study.

BJUI compass·2025
Same author

Transformer-based deep learning model for the diagnosis of suspected lung cancer in primary care based on electronic health record data.

EBioMedicine·2024
Same author

Association between kidney function, frailty and receipt of invasive management after acute coronary syndrome.

Open heart·2024
Same author

Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data.

BMC cardiovascular disorders·2024

Related Experiment Video

Updated: Apr 16, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.1K

Management of erectile dysfunction post-radical prostatectomy.

Alan Saleh1, Hamid Abboudi1, Mb Ghazal-Aswad1

  • 1Division of Surgery and Cancer, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK.

Research and Reports in Urology
|March 10, 2015
PubMed
Summary

Erectile dysfunction after radical prostatectomy lacks a standard treatment. Prompt management with PDE5 inhibitors, VEDs, or intracavernosal injections is recommended, with penile implants as a last resort.

Keywords:
erectile dysfunctionintracavernosal injectionsintraurethral suppositoriesphosphodiesterase 5 inhibitorsvacuum erection devices

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

10.0K
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

2.1K

Related Experiment Videos

Last Updated: Apr 16, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

4.1K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

10.0K
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

2.1K

Area of Science:

  • Urology
  • Andrology
  • Sexual Medicine

Background:

  • Radical prostatectomy for localized prostate cancer can lead to long-term erectile dysfunction (ED).
  • Optimal management strategies for post-prostatectomy ED remain unclear, highlighting a significant unmet clinical need.
  • Early intervention is crucial to prevent penile fibrosis and maintain tissue oxygenation.

Purpose of the Study:

  • To review current management approaches for erectile dysfunction following radical prostatectomy.
  • To discuss the efficacy and limitations of existing treatment modalities.
  • To explore emerging therapeutic options for post-prostatectomy ED.

Main Methods:

  • Review of current literature on erectile dysfunction management post-radical prostatectomy.
  • Analysis of first-line therapies including phosphodiesterase 5 inhibitors (PDE5i).
  • Evaluation of combination therapies (e.g., vacuum erection devices, alprostadil suppositories) and second/third-line options (intracavernosal injections, penile prosthesis).

Main Results:

  • Current treatment relies on a stepwise approach, often initiated with PDE5 inhibitors.
  • Combination therapies and intracavernosal injections are used for non-responders.
  • Penile prosthesis implantation represents a definitive but invasive option for refractory ED.
  • Management plans are often individualized, lacking uniform protocols due to limited high-quality evidence.

Conclusions:

  • There is no universally accepted, objective treatment program for erectile dysfunction after radical prostatectomy.
  • Prompt initiation of treatment, patient expectation management, and realistic timelines are vital.
  • Emerging therapies like dietary supplements and gene therapy show potential but require further clinical validation.